Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew McGuire

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Cancers|November 26, 2022
Insights into Biochemical Sources and Diffuse Reflectance Spectral Features for Colorectal Cancer Detection and LocalizationMarcelo Saito Nogueira, Siddra Maryam, Michael Amissah, et al.
Open Forum Infectious Diseases|December 15, 2022
Epstein-Barr Virus Glycoprotein Antibody Titers and Risk of Nasopharyngeal CarcinomaAnna E Coghill, Andrew McGuire, Sweta Sinha, et al.
The Breast Journal|February 1, 2017
Contrast-Enhanced Spectrum Mammography-A Useful Adjunct to Digital Mammography in Predicting Tumor SizeAndrew McGuire, Donal Peter O'Leary, Vicki Livingstone, et al.
Irish Journal of Medical Science|December 21, 2023
Validation and comparison of two new scoring systems for the prediction of complicated versus uncomplicated appendicitisSiobhan Clifford, Andrew McGuire, Amenah Dhannoon, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
Peripheral Blood Cell Ratios as Prognostic Indicators in a Neoadjuvant Chemotherapy-Treated Breast Cancer CohortAmirhossein Jalali, David Miresse, Matthew R Fahey, et al.
Breast Cancer Research and Treatment|April 6, 2017
Differential impact of hormone receptor status on survival and recurrence for HER2 receptor-positive breast cancers treated with TrastuzumabAndrew McGuire, Olga Kalinina, Emma Holian, et al.
BMC Cancer|March 15, 2018
Correction to: Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment optionsPeter F McAnena, Andrew McGuire, A Ramli, et al.
Medical Teacher|May 14, 2024
Was it all worth it? A graduating resident perspective on CBMEPortia Kalun, Heather Braund, Natalie McGuire, et al.
BMC Cancer|February 22, 2018
Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment optionsPeter F McAnena, Andrew McGuire, A Ramli, et al.
Cancer Pathogenesis and Therapy|March 20, 2026
Healthcare costs and health outcomes analysis of neoadjuvant Trastuzumab therapy for human epidermal growth factor receptor 2 (HER2) positive breast cancerAmirhossein Jalali, Shirin Moghaddam, Andrew McGuire, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Cancers|November 26, 2022
Insights into Biochemical Sources and Diffuse Reflectance Spectral Features for Colorectal Cancer Detection and LocalizationMarcelo Saito Nogueira, Siddra Maryam, Michael Amissah, et al.
Open Forum Infectious Diseases|December 15, 2022
Epstein-Barr Virus Glycoprotein Antibody Titers and Risk of Nasopharyngeal CarcinomaAnna E Coghill, Andrew McGuire, Sweta Sinha, et al.
The Breast Journal|February 1, 2017
Contrast-Enhanced Spectrum Mammography-A Useful Adjunct to Digital Mammography in Predicting Tumor SizeAndrew McGuire, Donal Peter O'Leary, Vicki Livingstone, et al.
Irish Journal of Medical Science|December 21, 2023
Validation and comparison of two new scoring systems for the prediction of complicated versus uncomplicated appendicitisSiobhan Clifford, Andrew McGuire, Amenah Dhannoon, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
Peripheral Blood Cell Ratios as Prognostic Indicators in a Neoadjuvant Chemotherapy-Treated Breast Cancer CohortAmirhossein Jalali, David Miresse, Matthew R Fahey, et al.
Breast Cancer Research and Treatment|April 6, 2017
Differential impact of hormone receptor status on survival and recurrence for HER2 receptor-positive breast cancers treated with TrastuzumabAndrew McGuire, Olga Kalinina, Emma Holian, et al.
BMC Cancer|March 15, 2018
Correction to: Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment optionsPeter F McAnena, Andrew McGuire, A Ramli, et al.
Medical Teacher|May 14, 2024
Was it all worth it? A graduating resident perspective on CBMEPortia Kalun, Heather Braund, Natalie McGuire, et al.
BMC Cancer|February 22, 2018
Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment optionsPeter F McAnena, Andrew McGuire, A Ramli, et al.
Cancer Pathogenesis and Therapy|March 20, 2026
Healthcare costs and health outcomes analysis of neoadjuvant Trastuzumab therapy for human epidermal growth factor receptor 2 (HER2) positive breast cancerAmirhossein Jalali, Shirin Moghaddam, Andrew McGuire, et al.
Pageof 3